Qway Research, LLC | Hialeah, FL
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
630 participants in 5 patient groups, including a placebo group
Loading...
Central trial contact
Trial Transparency email recommended (Toll free number for US and Canada)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal